Adjuvant-Induced Arthritis in Rats - ChemPartner

Skip to content

Solutions & Capabilities
Solutions & Capabilities

Discovery Chemistry

Biologics Discovery

Translational Science

DMPK & Toxicology

Bioprocess Development & Manufacturing

Discovery Chemistry

Turn promising hits into optimized leads with integrated medicinal, synthetic, and computational chemistry.

Read overview

Medicinal Chemistry

Design-driven hit-to-lead and lead optimization guided by SAR.

PROTAC / ADC Chemistry

Degrader and ADC design, from linker chemistry to payload.

Scale-up Chemistry

Route scouting and scale-up that carry your series toward the clinic.

Synthetic Chemistry

Complex synthesis and route design across novel chemical space.

Peptide Chemistry

Design and synthesis of peptides and peptidomimetics.

Process Chemistry

Robust, reproducible routes ready for GMP manufacturing.

Computational Chemistry / AIDD

AI-driven design, modeling, and virtual screening to focus effort.

Library Chemistry

Focused and diverse libraries to enrich your screening deck.

Biologics Discovery

Discover and engineer better biologics from antibody campaigns through protein production and developability, with fully integrated discovery-stage science.

Read overview

Antibody Discovery

Campaigns across display and immunization to find binders that perform.

Hybridoma

Phage Display

B Cell Screening

Affinity Maturation

Protein Engineering

Engineer affinity, stability, and function into every candidate.

ADC Engineering

Conjugate design and optimization across linkers and payloads.

Protein Production

Expression and purification of research- to lead-grade protein.

Bispecific Engineering

Multispecific formats designed for developability and function.

Developability Assessment

Early liability screening to de-risk candidates before you commit.

Translational Science

Bridge molecule and disease with the assays, biomarkers, and models that build biological confidence before your program reaches the clinic.

Read overview

Molecular Biology

Cloning, constructs, and cell engineering to enable your assays.

Biochemistry

Mechanistic and binding assays that quantify how your molecule acts.

Cell-Based Assays

Phenotypic and target-based assays that model biology in the dish.

Functional Assays

Functional readouts that connect target engagement to effect.

Biomarker Analysis

Identify and validate biomarkers that translate to the clinic.

Disease Models

In vitro and in vivo models built to reflect human disease.

Immunology Platforms

Immune-focused assays and models for immuno-oncology and beyond.

Oncology Platforms

Purpose-built oncology models and assays across tumor types.

Neuroscience Platforms

CNS models and assays for neurodegeneration and neurobiology.

DMPK & Toxicology

Understand how your compound behaves and where risk lives, with in vitro ADME, PK/PD, and GLP-ready toxicology built toward a confident IND.

Read overview

In Vitro ADME

Absorption, metabolism, and stability profiling to guide design.

Pharmacokinetics

In vivo pharmacokinetics across species to characterize exposure.

Bioanalysis

Validated LC-MS/MS and ligand-binding assays for every study.

PK/PD

Link exposure to effect to inform dose and design.

Exploratory Toxicology

Early tox screening to surface liabilities before you commit.

GLP Toxicology

GLP-compliant safety studies built toward a confident IND.

Histopathology

Board-certified pathology to interpret tissue-level findings.

Immunogenicity

Assess anti-drug antibody risk across biologics and modalities.

Safety Pharmacology

Core-battery safety assessment across vital organ systems.Focused and diverse libraries to enrich your screening deck.

Bioprocess Development & Manufacturing

Move from lab-scale to clinical supply with process, formulation, and GMP manufacturing designed to keep your timeline on track.

Read overview

Cell Line Development

Stable, high-yield clones selected for productivity and quality.

Process Development

Upstream and downstream processes optimized for scale.

Formulation Development

Stable formulations that protect your molecule to the clinic.

Scale-up

Tech transfer and scale-up that hold quality as volume grows.

GMP Manufacturing

GMP supply of drug substance and product for clinical trials.

Biologics Manufacturing

Antibody and protein manufacturing from cell line to fill.

Aseptic Filling

Sterile fill-finish of clinical drug product.

Freeze Drying

Lyophilization cycle development for stability and shelf life.

Extractables & Leachables

E&L studies to ensure container and process safety.
Modalities

Modalities Overview

Small Molecules

Biologics Discovery to IND & CRO/CDMO Solutions

Small Molecules

Small molecule discovery and development chemistry, from hit to IND.

Read overview

PROTAC

Bifunctional degraders that harness the ubiquitin-proteasome system.

Protein Degrader

Small molecules designed to selectively degrade target proteins.

Molecular Glue

Compounds that induce new protein-protein interactions.

Biologics & Advanced Biologics

Biologics discovery, development, and CDMO manufacturing solutions.

Read overview

Monoclonal Antibodies

Single-target antibodies for precise, high-affinity binding.

ADC / RDC

Antibodies conjugated to cytotoxic or radioactive payloads.

Bispecific Antibodies

Antibodies engineered to bind two distinct targets at once.

Peptides & Peptide-Drug Conjugate

Peptide therapeutics and peptide-drug conjugate development.

RNA Therapeutics

mRNA and oligonucleotide therapeutics from design to scale-up.

Gene Therapy

Viral and non-viral vectors for in vivo and ex vivo gene delivery.

Cell Therapies

CAR-T and cell-based therapies from process to manufacturing.
Therapeutic Areas

Therapeutic Areas Overview

Neuroscience

Immunology & Inflammation

Oncology & Immuno-Oncology

Metabolic Diseases

Cardiovascular

Infectious Diseases

Neuroscience

Build confidence in CNS programs with neuroscience-specific biology, pharmacology, and models across neurodegeneration and neurobiology.

Read overview

CNS Biology

Cellular and molecular neuroscience to characterize target biology.

Neuropharmacology

In vivo and in vitro pharmacology tailored to CNS targets.

Neuro Models

Disease models spanning neurodegeneration and neurodevelopment.

Immunology & Inflammation

Interrogate immune and inflammatory pathways with translational assays and models built to de-risk autoimmune and inflammatory targets.

Read overview

Autoimmune Disease

Models spanning the major autoimmune indications and mechanisms.

Inflammation

Acute and chronic inflammation readouts across tissues and pathways.

Oncology & Immuno-Oncology

Advance oncology and immuno-oncology programs with disease-relevant models spanning solid tumors, hematologic malignancies, and tumor immunity.

Read overview

Solid Tumor

Cell-line and patient-derived models across major solid tumor types.

Hematology Malignancies

Models and assays for leukemia, lymphoma, and myeloma programs.

Tumor Immunology

Assays that probe how the immune system engages the tumor.

Metabolic Diseases

Support metabolic and cardiometabolic programs with models that reflect the biology of obesity, diabetes, and related disease.

Read overview

Obesity / Metabolism

Models and endpoints for obesity, diabetes, and energy metabolism.

Cardiometabolic Biology

Assays bridging metabolic dysfunction and cardiovascular risk.

Cardiovascular

Advance cardiovascular programs with lipid and cardiovascular biology models built to translate to clinical endpoints.

Read overview

Lipid Biology

Lipid and lipoprotein assays for dyslipidemia and related targets.

Cardiovascular Biology

Cardiac and vascular models across major cardiovascular indications.

Infectious Diseases

Target pathogens and the host response with anti-infective and host–pathogen models across bacterial, viral, and immune biology.

Read overview

Anti-infective Biologics

Discovery of biologics targeting bacterial and viral pathogens.

Host-Pathogen / Immune Response

Assays mapping how pathogens and the immune system interact.
Integrated Programs

Explore Integrated Programs

Small Molecule Discovery to PCC / IND

Biologics Discovery to IND & CRO/CDMO Solutions

Small Molecule Discovery to PCC / IND

Chemistry-driven programs spanning hit discovery through IND filing.

Read overview

Discovery to PCC

Hit-to-lead chemistry advancing candidates to preclinical selection.

Discovery to IND

End-to-end chemistry support from candidate to IND submission.

Pharmacology, DMPK & Toxicology

In vitro and in vivo studies to characterize safety and exposure.

CMC Development

Process chemistry and manufacturing controls for scale-up readiness.

Regulatory Support

Regulatory strategy and filing support through every development stage.

Biologics Discovery to IND & CRO/CDMO Solutions

Integrated biologics programs from antibody discovery to CDMO manufacturing.

Read overview

Ab Discovery to IND

Antibody discovery and engineering through IND-enabling studies.

ADC to IND

Conjugation chemistry and process development for ADC candidates.

Biologics CRO Solutions

Contract research services spanning biologics discovery and testing.

Biologics CDMO Solutions

Contract development and manufacturing for biologic therapeutics.

Integrated Discovery-to-CMC Programs

Seamless handoff from discovery through CMC development.
Resources

Explore Resources

Case Studies

Resource Library

Insights

Events

Case Studies

Real-world programs showcasing our discovery and development work.

View case studies

01

A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition

Aberrant metabolism of cancer cells is well appreciated, but the identification of cancer subsets with specific metabolic vulnerabilities remains challenging.

Read case study

02

Boosting mRNA Therapeutics: pHLIP Enhances Endosomal Escape and Gene Expression in Lipid Nanoparticle

Messenger RNA (mRNA) has emerged as a transformative technology for combating viral pandemics and malignancies, with lipid nanoparticle (LNP)-based mRNA vaccines playing a pivotal role in the COVID-19 pandemic.

Read case study

Resource Library

Technical resources supporting your drug discovery and development.

View resources

White Papers

In-depth technical papers on our discovery and development platforms.

Technical Notes

Concise notes on methods, protocols, and technical best practices.

Publications

Peer-reviewed publications featuring our scientific research.

Insights

Perspectives and updates from our scientific and technical teams.

View insights

Blog

Perspectives and updates from our scientists and program teams.

News

Company announcements and the latest ChemPartner updates.

Events

Webinars, conferences, and workshops from our global team.

View events

Webinars

Live and on-demand sessions covering key scientific topics.

Conferences

Meet our team at major industry conferences worldwide.

Workshops

Hands-on sessions exploring our discovery and development capabilities.
About

Our Story

How ChemPartner grew into a global CRO/CDMO partner.

Leadership

Meet the executives guiding our strategy.

Global Locations

Labs and offices across Asia, the US, and Europe.

Newsroom

Company news, milestones, and media coverage.

Partnerships

Strategic alliances that extend our discovery reach.

Investor Relationships

Financial reports and updates for our investors.

ESG & Sustainability

Our commitments to people, planet, and governance.

Careers

Explore open roles across our global teams.

Search

Solutions & Capabilities
Modalities
- Small Molecule
- Biologics Discovery to IND & CRO/CDMO Solutions
Therapeutic Areas
Integrated Programs
- Small Molecule Discovery to PCC / IND
- Biologics Discovery to IND & CRO/CDMO Solutions
Resources
About
Contact

Solutions & Capabilities
Modalities
- Small Molecule
- Biologics Discovery to IND & CRO/CDMO Solutions
Therapeutic Areas
Integrated Programs
- Small Molecule Discovery to PCC / IND
- Biologics Discovery to IND & CRO/CDMO Solutions
Resources
About
Contact

Animal: Lewis rat, female, 180-200g

Immunizations: CFA

Readouts: body weight, joint swelling, clinical score, pathology, x-ray

Leading CRO/CDMO providing comprehensive drug discovery and development services to the global biopharmaceutical industry.

Services & Platforms

Discovery Chemistry
Biologics Discovery
Translational Science
DMPK & Toxicology
Bioprocess Development & Manufacturing

Modalities

Modalities Overview
Small Molecules CMC
Antibody Discovery & Engineering
ADC / RDC

Therapeutic Areas

Therapeutic Areas Overview
Neuroscience
Immunology & Inflammation
Oncology/Immuno-oncology

Integrated Programs

Integrated Programs Overview

Small molecule Discovery to PCC/ IND
Biologics Discovery to IND & CRO/CDMO Solutions

Resources

Insights
Case Studies
Resource Library
Events

About

Our Story
Global Locations
Leadership
ESG & Sustainability
Careers

©2026 ChemPartner. All rights reserved. Strength in Science, Flexibility in Partnership.

START YOUR JOURNEY

Phase

Modality

Therapeutic Area

English

中文 (简体)